RO62274A - Procede pour la preparation des derives de pyridine - Google Patents

Procede pour la preparation des derives de pyridine

Info

Publication number
RO62274A
RO62274A RO7300074369A RO7436973A RO62274A RO 62274 A RO62274 A RO 62274A RO 7300074369 A RO7300074369 A RO 7300074369A RO 7436973 A RO7436973 A RO 7436973A RO 62274 A RO62274 A RO 62274A
Authority
RO
Romania
Prior art keywords
preparation
pyridine derivatives
pyridine
derivatives
Prior art date
Application number
RO7300074369A
Other languages
English (en)
Romanian (ro)
Inventor
Edward D Thorne
Kurt Engel
Original Assignee
Robapharm Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robapharm Ag filed Critical Robapharm Ag
Publication of RO62274A publication Critical patent/RO62274A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
RO7300074369A 1972-04-04 1973-04-03 Procede pour la preparation des derives de pyridine RO62274A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1528072A GB1437781A (en) 1972-04-04 1972-04-04 Pyridine derivatives having hypoglycaemic activity

Publications (1)

Publication Number Publication Date
RO62274A true RO62274A (fr) 1977-12-15

Family

ID=10056262

Family Applications (2)

Application Number Title Priority Date Filing Date
RO7300074369A RO62274A (fr) 1972-04-04 1973-04-03 Procede pour la preparation des derives de pyridine
RO7300083382A RO63069A (fr) 1972-04-04 1973-04-03 Procede pour la preparation des derives pyridine

Family Applications After (1)

Application Number Title Priority Date Filing Date
RO7300083382A RO63069A (fr) 1972-04-04 1973-04-03 Procede pour la preparation des derives pyridine

Country Status (20)

Country Link
JP (1) JPS49100091A (fr)
AR (1) AR208269A1 (fr)
AT (1) AT339301B (fr)
BE (1) BE797715A (fr)
BG (1) BG20352A3 (fr)
CA (1) CA999868A (fr)
CH (1) CH576961A5 (fr)
CS (1) CS183689B2 (fr)
DD (1) DD106834A5 (fr)
DE (1) DE2316881A1 (fr)
ES (1) ES413279A1 (fr)
FR (1) FR2182933B1 (fr)
GB (1) GB1437781A (fr)
HU (1) HU165731B (fr)
IE (1) IE37412B1 (fr)
IL (1) IL41825A (fr)
NL (1) NL7304610A (fr)
PL (1) PL96043B1 (fr)
RO (2) RO62274A (fr)
ZA (1) ZA731853B (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4409227A (en) 1979-08-09 1983-10-11 The Dow Chemical Co. 4-(((Heterocyclo)thio)methyl)benzoic acids, esters and amides and their pharmaceutical use
DK0530864T3 (da) * 1991-07-03 1995-08-28 Unilever Plc Forbedrede chokoladesammensætninger
DE69204231T2 (de) * 1991-07-03 1996-01-25 Unilever Nv Pralinenfüllung enthaltend ein Zusatzmittel gegen Fettbelag.
US5453433A (en) * 1994-05-13 1995-09-26 Sterling Winthrop Inc. Thiadiazoles and antipicornaviral compositions
JP2000509373A (ja) * 1996-04-19 2000-07-25 ノボ ノルディスク アクティーゼルスカブ ホスホチロシン認識ユニットを有する分子のモジュレーター
US6043247A (en) * 1996-04-19 2000-03-28 Novo Nordisk A/S Modulators of molecules with phosphotyrosine recognition units
US6329372B1 (en) 1998-01-27 2001-12-11 Celltech Therapeutics Limited Phenylalanine derivatives
EP1056714B1 (fr) 1998-02-26 2004-08-11 Celltech Therapeutics Limited Derives de phenylalanine en tant qu'inhibiteurs d'integrines alpha 4
GB9805655D0 (en) 1998-03-16 1998-05-13 Celltech Therapeutics Ltd Chemical compounds
US6521626B1 (en) 1998-03-24 2003-02-18 Celltech R&D Limited Thiocarboxamide derivatives
GB9811159D0 (en) 1998-05-22 1998-07-22 Celltech Therapeutics Ltd Chemical compounds
GB9811969D0 (en) * 1998-06-03 1998-07-29 Celltech Therapeutics Ltd Chemical compounds
GB9812088D0 (en) 1998-06-05 1998-08-05 Celltech Therapeutics Ltd Chemical compounds
GB9814414D0 (en) * 1998-07-03 1998-09-02 Celltech Therapeutics Ltd Chemical compounds
GB9821061D0 (en) 1998-09-28 1998-11-18 Celltech Therapeutics Ltd Chemical compounds
GB9821222D0 (en) 1998-09-30 1998-11-25 Celltech Therapeutics Ltd Chemical compounds
GB9825652D0 (en) 1998-11-23 1999-01-13 Celltech Therapeutics Ltd Chemical compounds
GB9826174D0 (en) 1998-11-30 1999-01-20 Celltech Therapeutics Ltd Chemical compounds
US6518283B1 (en) 1999-05-28 2003-02-11 Celltech R&D Limited Squaric acid derivatives
US6534513B1 (en) 1999-09-29 2003-03-18 Celltech R&D Limited Phenylalkanoic acid derivatives
US6455539B2 (en) 1999-12-23 2002-09-24 Celltech R&D Limited Squaric acid derivates
ATE375330T1 (de) 2000-04-17 2007-10-15 Ucb Pharma Sa Enamin-derivate als zell-adhäsionsmoleküle
US6403608B1 (en) 2000-05-30 2002-06-11 Celltech R&D, Ltd. 3-Substituted isoquinolin-1-yl derivatives
US6545013B2 (en) 2000-05-30 2003-04-08 Celltech R&D Limited 2,7-naphthyridine derivatives
WO2002004426A1 (fr) 2000-07-07 2002-01-17 Celltech R & D Limited Derives d'acide squarique contenant un noyau heteroaromatique bicyclique comme antagonistes d'integrine
EP1305291A1 (fr) 2000-08-02 2003-05-02 Celltech R&D Limited Derives d'isoquinoline-1-yl substitues en 3
EP1461323B1 (fr) * 2001-06-12 2013-10-09 Wellstat Therapeutics Corporation Composes destines au traitement de troubles metaboliques
GB0405033D0 (en) * 2004-03-05 2004-04-07 Karobio Ab Novel pharmaceutical compositions
TWI490214B (zh) * 2008-05-30 2015-07-01 艾德克 上野股份有限公司 苯或噻吩衍生物及該等作為vap-1抑制劑之用途
WO2015000900A2 (fr) * 2013-07-01 2015-01-08 Givaudan Sa Composés organiques
WO2016167153A1 (fr) * 2015-04-15 2016-10-20 長谷川香料株式会社 Modulateur d'arôme comprenant un dérivé de la pyridine ou un sel de celui-ci en tant que principe actif
EP3440052B1 (fr) 2016-04-06 2023-10-25 University Of Oulu Composés pour utilisation dans le traitement du cancer

Also Published As

Publication number Publication date
NL7304610A (fr) 1973-10-08
IL41825A0 (en) 1973-05-31
BE797715A (fr) 1973-10-03
CH576961A5 (fr) 1976-06-30
AT339301B (de) 1977-10-10
IL41825A (en) 1977-03-31
GB1437781A (en) 1976-06-03
CA999868A (en) 1976-11-16
RO63069A (fr) 1978-08-15
ZA731853B (en) 1974-01-30
FR2182933B1 (fr) 1976-05-14
BG20352A3 (fr) 1975-11-05
CS183689B2 (en) 1978-07-31
DE2316881A1 (de) 1973-10-11
IE37412L (en) 1973-10-04
JPS49100091A (fr) 1974-09-20
PL96043B1 (pl) 1977-11-30
HU165731B (fr) 1974-10-28
DD106834A5 (fr) 1974-07-05
AR208269A1 (es) 1976-12-20
ATA286773A (de) 1977-02-15
FR2182933A1 (fr) 1973-12-14
ES413279A1 (es) 1976-01-01
IE37412B1 (en) 1977-07-20

Similar Documents

Publication Publication Date Title
RO62274A (fr) Procede pour la preparation des derives de pyridine
RO72460A (fr) Procede pour la preparation des derives de n-phosphomethylglycines
RO62914A (fr) Procede pour la preparation des derives des 2-alkylaminodihydropyridines
RO64607A (fr) Procede pour la preparation des derives du 1-phenoxy-3-aminopropan-2-ole
CH553207A (fr) Procede pour la preparation de derives azotes.
BE808316A (fr) Procede pour la preparation de beta-alcoxy-omega-lactames
RO62662A (fr) Procede pour la preparation des derives du oxindol
RO62808A (fr) Procede pour la preparation de phenylaniline et des derives
RO71937A (fr) Procede pour la preparation des derives de benzodioxole
RO63006A (fr) Procede pour la preparation des derives du 2-hydrazinobenzthiazole
RO62801A (fr) Procede pour la preparation des derives 3-substitues du ryphamicyne
BE772818A (fr) Procede pour la preparation de derives de
RO65263A (fr) Procede pour la preparation des derives de 6-aza-3h-benzodiazepines
RO76964A (fr) Procede pour la preparation des derives de neriifoline
RO69383A (fr) Procede pour la preparation des derives de phtalimide
BE806255A (fr) Procede de preparation de derives de la morphanthridinone
BE801225A (fr) Procede pour la preparation de derives de tricyclohe xyletain
RO62337A (fr) Procede pour la preparation des derives de 22-fluor-digoxine
RO70575A (fr) Procede pour la preparation des derives de benzhydrole-alpha-substitus
BE807113A (fr) Procede pour la preparation de delta-cetoesters
RO66744A (fr) Procede pour la preparation des derives de isoxazolidine
BE747826A (fr) Procede pour la preparation de derives de pyridine
RO64593A (fr) Procede pour la preparation des derives du cyclobutane
BE802233A (fr) Procede pour la preparation de derives de benzodiazepine
RO68363A (fr) Procede pour la preparation des derives de thyrisine